BioNTech and Pfizer's coronavirus vaccine shows potential in human trial

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.
via FOX BUSINESS NEWS https://ift.tt/3ghiWpv
No comments:
Post a Comment